抗菌敏感性測試市場規模、佔有率和成長分析（按產品、類型、方法、應用、最終用戶和地區）- 2025-2032 年產業預測

2023 年抗生素敏感性測試市場規模價值 44 億美元，預計將從 2024 年的 46.3 億美元成長到 2032 年的 69.4 億美元，預測期內（2025-2032 年）的複合年成長率為 5.2%。

抗菌藥敏測試（AST）市場是醫療保健產業不可或缺的一部分，尤其是在感染疾病和微生物控制領域。隨著全球抗生素抗藥性細菌的快速增加和感染疾病的增多，對可靠診斷技術的需求日益增加。自動化和先進的分子生物學技術等創新將提高 AST 的準確性和效率。然而，AST 技術高成本、缺乏標準化和程序複雜等挑戰可能會阻礙市場成長，尤其是在中低收入地區。儘管存在這些障礙，但市場仍然提供了機會，特別是隨著即時診斷和再生醫學的進步。預計未來一年美國AST 市場將持續成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究分析
• 專利分析

抗菌敏感性測試市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 耗材
  • 文化與成長媒體
  • 敏感度測試盤
  • 麥克風帶
  • 敏感度測試板
• 實驗室設備
  • 自動化實驗室設備
  • 分子診斷系統
• 實驗室耗材

抗菌敏感性測試市場規模（按類型和複合年成長率）（2025-2032）

• 市場概況
• 抗菌藥物敏感性測試
• 抗真菌藥物敏感性試驗
• 抗寄生蟲藥敏試驗
• 抗病毒藥敏試驗

抗菌敏感性測試市場規模（按方法和複合年成長率） (2025-2032)

• 市場概況
• 定性方法
  • 抗菌藥物敏感性測試
  • 磁碟擴充
  • 瓊脂稀釋
  • 基因分型方法
• 定量方法
  • ETEST 方法
  • 肉湯宏觀稀釋

抗菌敏感性測試市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概況
• 臨床診斷
• 藥物研發
• 流行病學
• 其他用途

抗菌敏感性測試市場規模（按最終用戶和複合年成長率分類）（2025-2032 年）

• 市場概況
• 醫院和診斷中心
• 製藥和生物技術公司
• 學術研究所
• 臨床研究所

抗菌敏感性測試市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific Inc.（US）
• Bio-Rad Laboratories, Inc.（US）
• Danaher Corporation（US）
• Becton, Dickinson and Company（US）
• bioMerieux SA（France）
• Roche Diagnostics（Switzerland）
• Abbott Laboratories（US）
• Bruker Corporation（US）
• Merck KGaA（Germany）
• Agilent Technologies, Inc.（US）
• ConvaTec Group plc（UK）
• HiMedia Laboratories Pvt. Ltd.（India）
• Liofilchem srl（Italy）
• Accelerate Diagnostics, Inc.（US）
• Creative Diagnostics（US）
• Bio-Rad Laboratories（US）
• Synbiosis（UK）
• QIAGEN NV（Germany）

結論和建議

Antimicrobial Susceptibility Testing Market size was valued at USD 4.4 billion in 2023 and is poised to grow from USD 4.63 billion in 2024 to USD 6.94 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The antimicrobial susceptibility testing (AST) market is a vital component of the healthcare industry, especially in managing infectious diseases and microbiology. Driven by the surge in antibiotic-resistant bacteria and the global rise in infectious diseases, there is an increasing demand for reliable diagnostic technologies. Innovations such as automation and advanced molecular methods enhance the accuracy and efficiency of AST. However, challenges such as the high cost of AST technologies, a lack of standardization, and complex procedures may hinder market growth, particularly in middle and low-income regions. Despite these obstacles, the market is presented with opportunities, particularly with the trend towards point-of-care testing and advancements in regenerative medicine. The US AST market is expected to experience sustainable growth in the coming forecast year.

Top-down and bottom-up approaches were used to estimate and validate the size of the Antimicrobial Susceptibility Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Antimicrobial Susceptibility Testing Market Segments Analysis

Global Antimicrobial Susceptibility Testing Market is segmented by Product, Type, Method, Application, End User and region. Based on Product, the market is segmented into Consumables, Lab Instruments and Lab Disposables. Based on Type, the market is segmented into Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing and Antiviral Susceptibility Testing. Based on Method, the market is segmented into Qualitative Methods and Quantitative Methods. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Epidemiology and Other Applications. Based on End User, the market is segmented into Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Clinical Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Antimicrobial Susceptibility Testing Market

The rise of Antimicrobial Resistance (AMR) poses a significant challenge to global health, prompting health organizations and authorities to emphasize the importance of effective Antimicrobial Susceptibility Testing (AST) to monitor resistance patterns. This testing plays a crucial role in informing treatment choices and promoting the appropriate use of antibiotics. Additionally, the increasing prevalence of infectious diseases, exacerbated by factors such as travel, urbanization, and population growth, necessitates timely diagnosis and treatment. Consequently, this surge in infectious cases fuels the demand for reliable and efficient AST, making it an essential component in the fight against AMR.

Restraints in the Antimicrobial Susceptibility Testing Market

The Antimicrobial Susceptibility Testing (AST) market faces several challenges, particularly in middle and low-income countries where there is a significant lack of awareness regarding the advantages of AST. This gap in understanding can hinder its widespread acceptance. Additionally, inadequate training of laboratory personnel on current testing methodologies further impedes the effective implementation of AST. Compounding these issues, the regulatory landscape governing diagnostic tools and solutions can be complex and time-consuming, with stringent requirements potentially delaying the launch of innovative AST technologies. Consequently, these factors may restrict the growth and accessibility of AST in certain regions.

Market Trends of the Antimicrobial Susceptibility Testing Market

The Antimicrobial Susceptibility Testing market is witnessing a significant trend toward the adoption of rapid testing techniques that deliver immediate results, transforming the landscape of pathogen detection and treatment decisions. Innovations such as mass spectrometry, molecular diagnostics, and automated systems are being rapidly developed to streamline the testing process, reducing turnaround times from days to mere hours. This shift is particularly impactful in critical care environments, where timely identification of bacterial resistance is vital for improving patient outcomes. As healthcare providers increasingly prioritize speed and accuracy in antimicrobial stewardship, the demand for rapid testing solutions is anticipated to surge, reshaping market dynamics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis
• Patent Analysis

Global Antimicrobial Susceptibility Testing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
  • Culture & Growth Media
  • Susceptibility Testing Disks
  • Mic Strips
  • Susceptibility Testing Plates
• Lab Instruments
  • Automated Laboratory Instruments
  • Molecular Diagnostics Systems
• Lab Disposables

Global Antimicrobial Susceptibility Testing Market Size by Type & CAGR (2025-2032)

• Market Overview
• Antibacterial Susceptibility Testing
• Antifungal Susceptibility Testing
• Antiparasitic Susceptibility Testing
• Antiviral Susceptibility Testing

Global Antimicrobial Susceptibility Testing Market Size by Method & CAGR (2025-2032)

• Market Overview
• Qualitative Methods
  • Automated Ast
  • Disk Diffusion
  • Agar Dilution
  • Genotypic Method
• Quantitative Methods
  • ETEST Method
  • Broth Macrodilution

Global Antimicrobial Susceptibility Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Diagnostics
• Drug Discovery & Development
• Epidemiology
• Other Applications

Global Antimicrobial Susceptibility Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Diagnostic Centers
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Clinical Research Organizations

Global Antimicrobial Susceptibility Testing Market Size & CAGR (2025-2032)

• North America (Product, Type, Method, Application, End User)
  • US
  • Canada
• Europe (Product, Type, Method, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Method, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Method, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Method, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ConvaTec Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiMedia Laboratories Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Liofilchem s.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accelerate Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbiosis (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations